Calithera Biosciences Funding & Investors
South San Francisco, CA
Calithera Biosciences is a development-stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer. They are applying Their scientific expertise to build a pipeline of unique anti- cancer drugs that selectively target metabolic and apoptotic pathways critical to tumor growth and survival.
calithera.comTotal Amount Raised: $341,400,000
Calithera Biosciences Funding Rounds
Post Ipo Equity
$10,000,000
Grant
$2,400,000
Grant Investors
Cystic Fibrosis FoundationPost Ipo Equity
$36,000,000
Post Ipo Equity
$57,500,000
Post Ipo Equity
$50,000,000
Post Ipo Equity
$80,500,000
Series Unknown
$15,999,998
IPO
Unknown
Series D
$35,000,000
Series D Investors
Adage Capital ManagementMorgenthalerAdvanced Technology VenturesDelphi VenturesLongwood FundSeries C
$2,000,000
Series C Investors
Delphi VenturesMorgenthalerAdvanced Technology VenturesSeries B
$8,000,000
Series Unknown
$4,000,000
Series Unknown Investors
U.S. Venture Partners (USVP)Advanced Technology VenturesMorgenthalerDelphi VenturesSeries A
$40,000,000
Series A Investors
MorgenthalerU.S. Venture Partners (USVP)Delphi VenturesMission Bay CapitalAdvanced Technology Ventures
Funding info provided by Diffbot.